Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy of combining inecalcitol with decitabine in acute myeloid leukemia patients who are unfit for standard chemothe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decitabine (Decitabine)
  • Inecalcitol (inecalcitol)

Snippet

Sponsor: Hybrigenics Corporation | Conditions: Acute Myelogenous Leukemia | Phase 2 | Status: UNKNOWN